Friday, March 12, 2010
Home HAAD News Events Feedback Contact Us Site Map  Login
  Search
Home

Poll
The Poison and Drug Information Center serves a vital and necessary function?



Submit Survey  View Results
PDIC ADVERTISEMENTS

Latest News
On 02/22/2010 FDA notified healthcare professional and patients that it is reviewing the primary data from a large, long-term clinical study, RECORD, on possible cardiovascular risks with the diabetes drug, AVANDIA (rosiglitazone).  
On 02/23/2010 FDA notified healthcare professionals and patients that it is reviewing clinical trial data about a potentially serious effect on the heart from the use of Invirase (saquinavir) in combination with Norvir (ritonavir), antiviral medications given together to treat HIV infection.
These products are not authorized for sale in Canada and UAE and have not been found in the Canadian marketplace. Information about their availability in the UAE is lacking. However, it is possible these products could be purchased by persons travelling abroad or have been brought into UAE through personal importation by travelers or purchased over the Internet.
 
 
Events